A comprehensive view of respiratory/lung health. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Moderna signs 10-year agreement with Australian federal government, Victorian government to work with Monash University to develop mRNA vaccine manufacturing plant; new plant to make up to 100 million respiratory virus vaccines annually

Seventy percent of patients concerned about tobacco corporations’ ownership of lung disease treatments; treatments include inhalers, medications, other devices

Sanofi, UK National Institute for Health and Care Research enrolling patients for clinical trial to evaluate injectable drug nirsevimab’s protection against respiratory syncytial virus in infants; trial to involve 20,000 infants in UK, France, Germany

Global bronchitis treatment market projected to grow by US$1.1B, have CAGR growth of 4.76%, from 2021 to 2026; growth driven by increase in smoking, as 32.51 million people smoked in US in 2020, 3.7 million smoke in Canada: Technavio

Novartis cancels filing for FDA approval of tislelizumab to treat non-small cell lung cancer after FDA decision to delay review of drug as esophageal squamous cell carcinoma treatment; Novartis paid BeiGene US$650M for rights to drug outside China

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count